Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online August 1, 2024.
Article Versions
- You are currently viewing a Latest version of this article (August 1, 2024 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2024 The Journal of Rheumatology
Author Information
- Dennis McGonagle,
- Kerem Abacar and
- Bruce Kirkham
- D. McGonagle, MD, PhD, Leeds Institute of the Rheumatic and Musculoskeletal Diseases, and Leeds Teaching Hospitals NHS Trust, Leeds.
- K. Abacar, MD, Leeds Institute of the Rheumatic and Musculoskeletal Diseases, and Leeds Teaching Hospitals NHS Trust, Leeds.
- B. Kirkham, MD, Kings College London, Rheumatology Department, Guy's & St Thomas' NHS Foundation Trust, London, UK.
-
As part of the supplement series GRAPPA 2023, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards.
KA is supported by Amgen Partner Fellowship Programme.
DM has received grant support and speaker bureau fees from AbbVie, BMS, Eli Lilly, Janssen, Novartis, Pfizer, and UCB. BK has been a consultant for and received speaker bureau fees from AbbVie, Eli Lilly, Galapagos, Janssen, Novartis, Pfizer, and UCB. KA declares no conflicts of interest relevant to this article.
This paper does not require institutional review board approval.
Accepted for publication June 17, 2024.
- Address correspondence to Dr. D. McGonagle, Leeds Institute of the Rheumatic and Musculoskeletal Diseases, Chapel Allerton Roads, University of Leeds, Leeds, LS7 4SA, UK. Email: meddgm{at}leeds.ac.uk.







